HOME >> MEDICINE >> NEWS
Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes

(PHILADELPHIA) -- While drug-eluting stents are effective in keeping open bypassed heart veins that arent too diffuse (filled with cholesterol plaque), a new study by cardiologists at Jefferson Medical College shows that they fare less well in keeping open bypassed veins with longer blockages. The researchers suggest that doctors think twice before inserting the drug-coated stents in such extensively diseased bypassed grafts.

The researchers looked at the success of drug-eluting stents in bypassed vein grafts and found that long-term success was dependent on the healthiness of the vessel. Lead researcher Nicholas J. Ruggiero II, M.D., a fellow in cardiovascular diseases, will present the results at the American College of Cardiologys 56th Annual Scientific Session on Monday, March 26, from 4 to 4:50 pm. (Abstract 916-214).

Seventy patients--61 men and nine women with a mean age of 70 years--were studied. Twenty eight (40 percent) of the patients had diabetes. The researchers divided the patients into those with focal disease (less than 30 millimeters of disease or fewer than three blockages in one vessel) or diffuse (extensive) disease (more than 30 millimeters of disease or three or more lesions in a single bypass).

Focal disease is considered to be less of a problem in the veins of patients who have undergone heart bypass surgery. Diffuse disease means that the artery is much more clogged and therefore at greater risk of re-clogging.

Thirty nine percent of the patients had diffuse disease. After one year, the researchers found that 84 percent of these patients were free of clinical restenosis (re-clogging) or disease in the drug-eluted stent bypasses. In patients with focal blockage, only three percent needed an additional procedure to treat restenosis after one year. In contrast, in patients with diffuse disease, 37 percent needed additional procedures to treat restenosis.

"To date, drug-eluting stents havent
'"/>

Contact: Nan Myers
nan.myers@jefferson.edu
215-955-6300
Thomas Jefferson University
26-Mar-2007


Page: 1 2

Related medicine news :

1. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
2. Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics
3. Jefferson immunology researchers show blood-brain barrier damage could affect MS severity
4. Jefferson scientists find that plavix appears to be safe during and after heart bypass
5. Treatment of in-hospital cardiac patients is focus of Jefferson University presentations
6. Empathy skills must be given a high priority in medical education, says Jefferson author
7. Natural, soy-based substance might help fight MS, Jefferson neuroscientists find
8. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
9. Obesity tied to higher risk of complications in spinal surgery, Jefferson neurosurgeon finds
10. Jefferson Orthopaedic surgeons leading international study of timing of spinal surgery
11. Jefferson scientists find boosting protein levels staves off heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... Spa Show 2021 will be held Wednesday, April 7, to Saturday, April 10, ... January. , Medical Spa Show is a national trade show for non-invasive medical ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... for healthcare payers administering Medicare Advantage and Special Needs plans, is proud to ... America’s Health Insurance Plans (AHIP). RAM is supporting the event as a sponsor ...
(Date:9/1/2020)... ... ... Feeding Matters , the first organization in the world dedicated to ... to announce that the U.S. Centers for Disease Control and Prevention (CDC) has officially ... of the U.S. International Classification of Diseases (ICD ) on October 1, 2021. ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons ... biomedical engineers from Carnegie Mellon University (CMU) to develop a new heart monitoring ... undergone open heart surgery. , The AGH/CMU team was recently awarded a “Trailblazer” ...
(Date:8/31/2020)... Miss. (PRWEB) , ... August 31, 2020 , ... ... (GCPP) recently donated 1,400 N95 face masks to medical first responders across the ... continued to make donations of personal protective equipment (PPE) medical centers , ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... ROCKWALL, Texas (PRWEB) , ... ... ... Preventative in the Fight Against Covid-19 , Advanced Penetration Technology, LLC, (APT) ... healthcare solutions for patients utilizing non-prescription, Over The Counter (OTC) products, was ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein Velez, ... at the University of Rochester Medical Center, in Upstate New York. She completed ... with clinical faculty from the Harvard and Yale Departments of Dermatology and is ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are ... (CDC), About 3% of breast cancers (about 7,500 women per year) and 10% of ... and BRCA2 genes. Both genes are detectable in the Women’s Excellence Genetic Testing ...
Breaking Medicine Technology:
Cached News: